X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Stem Cell Community Day 2019: Bringing the global stem cell research community together on November 21 in Portugal

Content Team by Content Team
11th July 2019
in Press Statements
Stem Cell Community Day 2019: Bringing the global stem cell research community together on November 21 in Portugal

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Following up on two successful events on recent advances in the stem cell field, Eppendorf is hosting the Stem Cell Community Day 2019. This year’s event will be held on November 21 at the Oitavos hotel in Cascais alongside the Sintra Mountains and Europe’s most westerly point (20 minutes west of Lisbon, Portugal).

As tiny as a stem cell might be, as enormous is its potential.

We invite all researchers from industry and academia to discuss recent challenges, opportunities, and achievements in stem cell bio-processing with a special focus on controlled cultivation in stirred-tank bioreactors.

This year’s Stem Cell Community Day will be chaired by Paula Alves, PhD, CEO of iBet – Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal. Further confirmed speakers are Margarida Serra, PHD (iBET), Felix Manstein (Hannover Medical School) and Arie Reijerkerk (Ncardia). Check our WEBSITE  for program and speaker updates.

Our scientific program includes an optional introductory stem cell workshop and presentations on challenges in bioprocess engineering and scale-up of stem cell culture, process controls and analytics as well as successful translation and commercialization. Lunch and coffee breaks will be provided. We will end the day with a dinner buffet and awarding the poster prize.

The Stem Cell Community Day invites scientists from academia and industry to submit abstracts for oral and poster presentations describing original research on appropriate topics. A jury will select the best three posters based on their scientific content and presentation. Have a chance to be awarded with the Eppendorf Stem Cell Community Day Poster Prize and win 1,000 EUR by submitting your abstract by October 1st.

Registration is free of charge and includes conference material, lunch, dinner buffet, coffee breaks and beverages. Travel and accommodation are not included.

We are excited to welcome you in Lisbon as we embark on a new journey towards the future of stem cell research!

Register now https://www.stemcellday.de/

Previous Post

Symposium tackles adulteration of botanical ingredients

Next Post

OmniSYS Acquires Clinical Pharmacy Services Provider STRAND Clinical Technologies

Related Posts

Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Next Post
OmniSYS Acquires Clinical Pharmacy Services

OmniSYS Acquires Clinical Pharmacy Services Provider STRAND Clinical Technologies

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In